Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2023 Sep 1;11(9):e007309corr1. doi: 10.1136/jitc-2023-007309corr1

Correction: Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development

PMCID: PMC10476104  PMID: 37657843

Kluger HM, Tawbi H, Feltquate D, et al. Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development. J ImmunoTher Cancer 2023;11:e007309. doi: 10.1136/jitc-2023-007309.

This article has been corrected since it was first published online. The author order was incorrect and has now been updated to the following: Hussein A Tawbi, Ryan J Sullivan, David Feltquate, Naiyer A Rizvi, Elad Sharon, Jeffrey Sosman, Harriet M Kluger. HAT and RJS contributed equally.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES